Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 [Yahoo! Finance]
Standard BioTools Inc. (LAB)
Company Research
Source: Yahoo! Finance
Revenues and losses per share were both better than expected, with revenues of US$45m leading estimates by 9.7%. Statutory losses were smaller than the analystsexpected, coming in at US$0.07 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. Check out our latest analysis for Standard BioTools Taking into account the latest results, the most recent consensus for Standard BioTools from three analysts is for revenues of US$188.2m in 2025. If met, it would imply a huge 21% increase on its revenue over the past 12 months. Losses are predicted to fall substantially, shrinking 34% to US$0.22. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$193.8m and losses of US$0.23 per sha
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Spatial Proteomics Market Projected to Reach USD 264.89 Million by 2032, Driven by a Strong 14.6% CAGR | Polaris Market Research [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Appoints Alex Kim as Chief Financial OfficerGlobeNewswire
- Standard BioTools Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Inc. (NASDAQ: LAB) had its price target lowered by analysts at TD Cowen from $2.75 to $2.50. They now have a "buy" rating on the stock.MarketBeat
- Standard BioTools to Participate in Upcoming Investor ConferencesGlobeNewswire
LAB
Earnings
- 10/30/24 - Beat
LAB
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form SC
- 11/12/24 - Form 144
- LAB's page on the SEC website